From population to patient:
Towards personalised breast cancer medicine
What is BREAST-PREDICT?
BREAST-PREDICT is a country-wide collaboration between experts in the area of breast cancer research, funded by the Irish Cancer Society. This ‘virtual Centre’ was launched in October 2013 and will run for a period of five years.
Who are we?
BREAST-PREDICT brings together researchers from six academic institutions across Ireland: UCD, TCD, RCSI, DCU, NUIG and UCC, and a nationwide clinical trials group, Cancer Trials Ireland (formerly ICORG).
What do we do?
We collect information and tumour samples from nearly every breast cancer patient in the country, with their consent. Using these valuable resources, we will improve our understanding of how this disease can spread and become resistant to treatment, and find ways to combat this with new and better therapies.
Why are we different to other research initiatives?
This is a multi-disciplinary Centre, which unites breast cancer experts with different skills, to work towards a common goal. This new collaborative approach brings together researchers from different areas, including:
How Can you Help?
- Connector.
BREAST-PREDICT is funded entirely on the proceeds of the Irish Cancer Society’s fundraising activities
- Connector.
This new collaborative approach to research brings together world-renowned experts with different skill sets
- Connector.
To accelerate the pace of scientific discovery and provide more treatment options for breast cancer patients, we need your help!
- Connector.
Visit www.cancer.ie or call Mark Mellett, the Irish Cancer Society Head of Fundraising, on
+353 (0)1 231 0500
Clinical Research
Surgeons
Medical Oncologists
Clinical Trials Staff
Translational Research
Laboratory Scientists
Computer Scientists
Pathologists
Population Research
Population scientists
Statisticians
Biobank staff
What is “Personalised breast cancer medicine”?
Our vision is that each breast cancer patient in Ireland should have their treatment plan tailored for their individual cancer. Most women diagnosed with breast cancer now survive, due to earlier diagnosis and improved treatments. Our goal is to better predict which therapies are best for each patient, thus giving all breast cancer patients the best possible chance at a long and healthy life.